Mueller, Melanie <br/><br/>
Inhibition of 3,4-methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4-dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: implications for mechanisms of neurotoxicity.  [electronic resource] 

 -  Synapse (New York, N.Y.)  Oct 2011 
 - 983-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1098-2396 
<br/><br/><label>Standard No.: </label>10.1002/syn.20925  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3,4-Methylenedioxyamphetamine--analogs & derivatives<br/>Animals<br/>Cytochrome P-450 Enzyme Inhibitors<br/>Cytochrome P-450 Enzyme System--metabolism<br/>Deoxyepinephrine--analogs & derivatives<br/>Dextromethorphan--pharmacology<br/>Excitatory Amino Acid Antagonists--pharmacology<br/>Hydroxyindoleacetic Acid--metabolism<br/>Male<br/>Neurotoxicity Syndromes--metabolism<br/>Neurotoxins--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Serotonin--metabolism<br/>Sulfides--chemistry